What most surprised experts about the pandemic three years in

Despite all the planning for a global pandemic, Covid-19 has not played out as expected. In short, we have a lot of learning left to do. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Three years on, the pandemic — and our response — have been jolting. Here's what even the experts didn't see coming By Helen branswell Kevin Frayer/Getty Images In the hope that important lessons for next time can be found in the things we didn’t anticipate this time, STAT asked 23 experts what had surprised them the most about the pandemic. The TL;DR version: We have a lot of learning left to do. Read More Sponsored insight by STAT+ Searching for the perfect gift? Get 3 months of STAT+ for $30. A STAT+ subscription gives you unlimited access to in-depth investigative journalism, groundbreaking analysis, subscriber-only newsletters, and industry event discounts. With a premium membership, you'll get your life sciences news direct from the source. For a limited time only, get three months of STAT+ for just $30. Subscribe now. More great reads from STAT this week Seeking maximum profits, Biogen set an ‘unjustifiably high price’ for Alzheimer’s treatment, investigation finds By Damian Garde and Adam Feuerstein Watch: The ‘fourth wave’ of the overdose crisis By Alex Hogan Eric Lander’s next act: leading a nonprofit set on solving thorny scientific challenges By Megan Molteni 3 things to watch in chronic disease in 2023: obesity drugs, long Covid and health care costs By Elaine Chen and Isabella Cueto 3 debates about addiction medicine to watch in 2023 By Lev Facher Get ready for ‘the electric vehicles of biopharma’: Three biotech trends to watch in 2023 By Damian Garde STAT’s most memorable photos of 2022 By Alissa Ambrose and Crystal Milner Most-read First Opinion essays of 2022 By Patrick Skerrett We wish we’d written that: STAT staffers share their favorite stories of 2022 By STAT staff Saturday, December 31, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser

Billing dispute backlog builds under No Surprises Act; overdoses hit the unhoused

Providers are swamping the government with billing disputes under the new law banning surprise medical bills. So far, just 4% have ended in payment.  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

STAT+: Providers seeking resolution of billing disputes under the No Surprises Act cause a major backlog of cases By Tara Bannow Mario Tama/Getty Images Only 4% of the 90,000 submissions to the federal dispute resolution process have resulted in a payment determination, HHS says in a report. Read More Watch: A wave of overdoses is hitting an already vulnerable population By Alex Hogan Scott Liberatore for STAT STAT rides along with physician Coley King in Santa Monica, Ca. to document how the "fourth wave" is impacting the unhoused. Read More Diabetes in youth is set to skyrocket in coming decades By Elaine Chen Alex Hogan/STAT If recent trends continue, type 2 diabetes among people younger than 20 could surge by about 700% over the next four decades, a new model predicts. Read More Sponsored Insight by STAT+ Searching for the perfect gift? Get 3 months of STAT+ for $30. A STAT+ subscription gives you unlimited access to in-depth investigative journalism, groundbreaking analysis, subscriber-only newsletters, and industry event discounts. With a premium membership, you’ll get your life sciences news direct from the source. For a limited time only, get three months of STAT+ for just $30. Subscribe now. We wish we'd written that: STAT staffers share their favorite stories of 2022 By STAT Staff Sylvia Plachy/Three Lions/Hulton Archive/Getty Images Our staff looks with admiration — and some envy — to journalists doing great reporting in reproductive health, health care, and more. Read More Wegovy may help teens with obesity lose weight but isn't a magic bullet By Elaine Chen STAT The FDA has approved Wegovy for weight loss among adolescents aged 12 years and older. Its usefulness in this age group remains to be seen. Read More Friday, December 30, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser

The 3 most expensive hospital construction projects in 2022

The latest stories trending on MedCity News.

Not rendering correctly? View this email as a web page here. TOP STORIES The MedCity News Daily will be paused on December 31 and January 2. Happy New Year! This Year's 3 Most Expensive Hospital Construction Projects Though hospitals' financial circumstances were dire this year, some multibillion dollar expansion projects have managed to move forward — including a the construction of a new $5 billion medical campus in Nevada and a new $4.3 billion hospital in San Francisco. Sponsored Content What's on Healthcare Executives' Agenda for 2023? From MedCity News At the 5th annual HLTH conference in Las Vegas, healthcare executives from companies including Jean Drouin of Clarify Health, responded to questions such as what's the fastest way to assess the latest trends in the healthcare market? They also previewed their plans for 2023. The Importance of Quality Assurance for Customer-Centric Medical Technology By Chuck Serrin Thursday, December 29, 2022 11:06 PM Having a streamlined process to get customer feedback, adhere to regulations, and automate processes not only helps make sure a business delivers the best quality products, but also helps ensure that customers are satisfied. Read more » What Will the Pharma Industry Face in the Year Ahead? By Natalie DiMambro Thursday, December 29, 2022 3:38 PM Many pharma and medical device companies will look inward, with the goal of standardizing and modernizing even highly regulated activities. Here's a closer look at some important industry trends for 2023. Read more » Survey: Americans Are Split on the Covid-19 Public Health Emergency By Marissa Plescia Thursday, December 29, 2022 2:00 PM About 51% of U.S. adults are in favor of the Covid-19 public health emergency still in effect, while 39% said it is no longer needed, a recent Morning Consult survey found. Americans' opinions varied based on political party, generation, race/ethnicity and location. Read more » Health Equity is Everyone's Business; Success Requires a Strategy Rooted in Community Voice and Data By Jay Bhatt and Kulleni Gebreyes Thursday, December 29, 2022 9:00 AM Our research has found that to advance ongoing work, community health ecosystems likely will need additional partners, shared goals, technology, and metrics. But most importantly, they will need the participation and leadership of more community members. Read more » SPONSORED Remote Patient Monitoring: How Medtech and Digital Health Can Collaborate to Generate RWE and Transform Patient Care In a new eBook, executives from Huma, Abbott, Smith & Nephew and AliveCor share how they are using RWE collection to support remote patient monitoring and improve patient outcomes in neurology, cardiology and orthopedic surgery. It also explores how medtech and digital health companies can collaborate to maximize patient engagement and to navigate regulatory requirements.    MedCity News   611 Broadway    New York,  NY   10012   United States You received this email because you are subscribed to MedCity Daily Digest from MedCity News. Update your email preferences to choose the types of emails you receive.  Unsubscribe from all future emails